Тhe issue of women´s rights and empowerment is one of EHRN`s key priorities: in 2017 we have finished our three year campaign „Women Against Violence“, which was focused on developing partnerships with law enforcement agencies and mobilizing women who use drugs.
New Psychoactive Substances among People Who Use Drugs Heavily. Towards Effective and Comprehensive Health Responses in Europe.
To celebrate 20 years since its inception, the World Drug Report 2017 is presented in a new five-booklet format designed to improve reader friendliness while maintaining the wealth of information contained within. Booklet 1 summarizes the content of the four subsequent substantive booklets and presents policy implications drawn from their findings. Booklet 2 deals with the supply, use and health consequences of drugs. Booklet 3 focuses on the cultivation, production and consumption of the three plant-based drugs (cocaine, opiates and cannabis) and on the impact of new cannabis policies. Booklet 4 provides an extended analysis of the global synthetic drugs market and contains the bulk of the analysis for the triennial global synthetic drugs assessment. Finally, Booklet 5 contains a discussion on the nexus between the drug problem, organized crime, illicit financial flows, corruption and terrorism.
Eastern Europe and Central Asia (EECA). In 2016, there were 1.6 million people living with HIV, there were an estimated 190 000 new HIV infections in the region. Between 2010 and 2016, the number of AIDS-related deaths increased by 27%. Treatment coverage is just 28% among people living with HIV in EECA. UNAIDS has released a new report which contains the highlights of the very latest data on the world’s response to HIV. The new report shows that the progress against the 90–90–90 targets has been poor in the region. However, there are exceptions showing that when concerted efforts are made, results happen. For example, Belarus has increased HIV treatment access from 29% in 2010 to 45% in 2016.
If you want to know the latest data about the European drug market, the new trends in drug use among European adults and youngsters and existing harm reduction programs in EU, explore the new 2017 European Drug Report. EN: http://www.emcdda.europa.eu/edr2017
In 2016-2017 Eurasian Harm Reduction Network has been supporting organization of a series of National Dialogues for government officials and NGOs in 6 countries to commit for Harm Reduction programs and their domestic funding. The National Dialogues were organized in the framework of the Regional Program “Harm Reduction Works – Fund It!”
In 2016-2017 Eurasian Harm Reduction Network has been organizing a series of study-tours for government officials and NGOs from Eastern Europe and Central Asia countries to examine harm reduction programs organization and funding in the neighboring countries, where the programs have been established for some time and successfully functioning. The study-tours were organized in the framework of the Regional Program “Harm Reduction Works – Fund It!”
Based on the regional and national reports, each participating country within the Regional program "Harm Reduction works!- fund it" developed its own national advocacy strategies "Harm Reduction Works - Fund It" that have been implemented by SRs and SSRs. The strategy included policy advocacy roundtables, working advocacy meetings, and other advocacy activities.It is two-year national advocacy plans for each of the participating country.
The 5 Country positions are documents that find consensus between the stakeholders on the transition to national funding of Harm Reduction. They were developed for the Regional Dialogue in Tbilisi (September 2015) and they were based on the results of investment monitoring research (IMG) on Harm Reduction financial needs. National authority representatives and representatives of PWUD communities together with national and international NGOs discussed the results of investment monitoring and built the country position on national Harm Reduction financial needs.
The workshop on 4-5 February, 2016 was set to address the following goals: • To develop understanding of the requirements of the Global Fund and EHRN to financial and program accountability; • To analyze reporting difficulties to reduce the number of errors in the financial and programmatic reports; • To develop the understanding of how the collected data can be used to evaluate effectiveness, to make reprogramming, and to implement advocacy.